Stock research
AbbVie Inc. ABBV
Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.
- Ticker
- ABBV
- Exchange
- NYSE
- Sector
- Health
- Founded
- 2013
What moves ABBV
AbbVie Inc. sits in Health Care. Pharmaceuticals, biotech, medical devices, and managed care — defensive demand paired with binary drug and regulatory catalysts. The forces that matter most for the sector — and therefore for ABBV — are:
- ◆Drug approvals and clinical-trial readouts
- ◆Medicare and drug-pricing policy
- ◆Demographics and an aging population
- ◆GLP-1 and obesity-drug demand
Congressional trading in ABBV
| Politician | Trade date | Type | Owner | Amount | Source |
|---|---|---|---|---|---|
| Josh Gottheimer | 2026-05-05 | Sale | Joint | $1,001 - $15,000 | Filing #20034693 |
Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.
The profile is free
ABBV research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.
How Yield Theory covers ABBV
ABBV intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.
Compare ABBV with similar companies
More Health Care stocks
ABBV — frequently asked questions
What sector is ABBV in?
AbbVie Inc. is classified in the Health Care sector and trades on the NYSE.
Do members of Congress trade ABBV?
The current verified House Clerk snapshot contains 1 transaction row for ABBV. Each row below links to the original filing.
Is ABBV a good investment?
We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.
Where is AbbVie Inc. headquartered?
AbbVie Inc. is headquartered in North Chicago, Illinois and was founded in 2013.
This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.
See whether the ABBV thesis still holds.
This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included